Saturday, April 08, 2006


Hepatitis C Therapy - Hepatitis C


Hepatitis C
... million people in the United States are infected with hepatitis C virus, and most do not know it ... a donor whose blood contained hepatitis C virus. Being on long-term ...

What I need to know about Hepatitis C
... The virus that causes hepatitis C is called the hepatitis C virus ...

Kennen Sie HEPATITIS C (HCV)? - Translate this page
... Hepatitis B- Virus. Hepatitis C- Virus. Hepatitis D- Virus ...

Hepatitis C (PDF)
... C is a liver disease caused by the hepatitis C virus (HCV), which is found in the blood ... who have this disease. Hepatitis C virus (HCV) infection is the most ...

NGC - Resources - Withdrawn NGC Summaries
Guideline Summary Archive. This feature provides a complete list of National Guideline Clearinghouse_ (NGC) Guideline Summaries (with NGC accession numbers) that have been withdrawn from the Web site.

Friday, April 07, 2006


Hepatitis C Therapy - PEG-INTRON : Interferon Treatment for Hepatitis C


PEG-INTRON : Interferon Treatment for Hepatitis C
Peginterferon alfa-2b Powder for injection is the first once-weekly pegylated interferon approved by the FDA and represents an advance in therapy for ...

MedlinePlus Drug Information: Peginterferon Alfa 2a ( Systemic)
Peginterferon alfa-2a is used to treat chronic hepatitis C. It is used for ... In deciding to use a medicine, the risks of using peginterferon alfa-2a must ...

Clinical Trial: Low-Dose Peginterferon and Ribavirin to Treat ...
This study will examine the effectiveness of low-dose peginterferon and ribavirin ... Drug: Peginterferon alfa-2a and ribavirin for chronic hepatitis C ...

NEJM -- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis ...
Original Article from The New England Journal of Medicine -- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected ...

Peginterferon for hepatitis C
Example(s): Pegasys (peginterferon alfa - 2a), Peg - Intron (peginterferon alfa - 2b) - ...

Protease Inhibitor - World Health Day observed at DMC


World Health Day observed at DMC
Ludhiana Newsline, India - 2 hours ago... parts of the country have been shocking where many of the thalassaemic children receiving regular blood transfusion contracted Hepatitis B, Hepatitis C and HIV ...

FDA Sends Intermune Letter Over Advertisement
PharmaLive.com (press release), PA - Apr 4, 2006... a proven treatment option for the significant and growing number of nonresponders and relapsers," referring to patients with chronic hepatitis C virus (HCV ...

The relentless clash of mortality, flesh, love and spirit
Australian, Australia - 10 hours ago... Once a fashion model, Alison is in her late 40s, hepatitis C positive, with an arm and neck ruined from accidents and dodgy surgery. ...

Hepatitis C Market: Plenty Of Potential, But Little Progress
Investor's Business Daily (subscription) - Mar 31, 2006The month of March was not kind to a pair of companies racing to find a cure or vaccine for hepatitis C, the often fatal liver disease that's been called a ...

Cuba Says It Has Developed New Treatment for Hepatitis C
International News Service, Australia - Mar 15, 2006Havana, Cuba: Cuba says it has developed a treatment against the hepatitis C virus that would contribute to a long-term cure of liver damage caused by the ...

Peginterferon - Ways You Can Get Infected With Hepatitis C(NC)-Hepatitis

Ways You Can Get Infected With Hepatitis C

(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:

Sharing needles, straws, pipes, spoons and other drug-related equipment.

(At least two-thirds of all new hepatitis C infections are drug-use related. Cleaning equipment with bleach does not always effectively kill the virus) p>

Getting a tattoo, body piercing or acupuncture from an operator who does not use sterile equipment or techniques

Being born to a mother with hepatitis C

Getting pierced by a needle or sharp equipment that has infected blood on it ( in a hospital, workplace situation, etc.) p>

People who had blood transfusions before the testing of blood donations became mandatory in 1990 may also be at risk. And, while the risk is low, it is also possible to become infected by sharing personal household articles such as a razor or toothbrush with an infected person. The risk of transmission of hepatitis C during sex is also low, unless both parties have open bleeding sores.

It is estimated that 240, 000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus.

If you think you may be at risk, either now or from past risky activities see a doctor. The virus can be detected with a simple blood test, and there are steps and medications you can take to successfully minimize the effects of the disease if your diagnosis is positive. For more information, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.


Thursday, April 06, 2006


Peginterferon - - Interim 12-Week Data Suggest At Least Comparable Antiviral ...


- Interim 12-Week Data Suggest At Least Comparable Antiviral ...
PR Newswire (press release), NY - Mar 14, 2006... The fourth treatment group serves as the active control group and receives 180-mcg doses of subcutaneously administered peginterferon alfa-2a (Pegasys) at 7 ...

MIGENIX to Present at BIO 2006
Yahoo! News (press release) - 4 hours ago... oral a-glucosidase I inhibitor for the treatment of chronic hepatitis C virus infections currently enrolling patients in combination with peginterferon alfa-2b ...

Gastroenterology issues probed
Trade Arabia, Bahrain - Apr 1, 2006... The study suggests that combination peginterferon alpha-2a (Pegasys) and Ribavirin is safely tolerated and effective at achieving eradication of Hepatitis C in ...

Valeant Pharmaceuticals Reports VISER1 Results for Viramidine(R) ...
Genetic Engineering News, NY - Mar 21, 2006... 1) NGI SuperQuant Assay, sensitivity to 39 IU/mL (100 copies/mL) (2) Defined as patients receiving 90% of peginterferon doses, 90% of ribavirin or Viramidine ...

Idenix Announces Thirteen Data Presentations at the 2006 European ...
PR Newswire (press release), NY - Mar 17, 2006... Dr. Zhou will present "Absence of Pharmacokinetic Drug-Drug Interaction Between Telbivudine and Peginterferon alfa-2a or Cyclosporine in Healthy Subjects" in ...

Wednesday, April 05, 2006


Peginterferon - ViRexx Announces Collaboration with Defence Research and ...


ViRexx Announces Collaboration with Defence Research and ...
CCNMatthews (press release), Canada - Mar 31, 2006... The Company is also conducting preclinical studies on Chimigen TM therapeutic vaccine candidates to treat chronic hepatitis C infections. ...

Novartis Announces in-licensing of Valopicitabine (NM283), a Novel ...
PharmaLive.com (press release), PA - Mar 29, 2006... its option from Idenix Pharmaceuticals to in-license the late-stage development compound valopicitabine (NM283) for the treatment of hepatitis C, a condition ...

Hepatitis C Market: Plenty Of Potential, But Little Progress
Investor's Business Daily (subscription) - Mar 31, 2006The month of March was not kind to a pair of companies racing to find a cure or vaccine for hepatitis C, the often fatal liver disease that's been called a ...

Gastroenterology issues probed
Trade Arabia, Bahrain - Apr 1, 2006A variety of topics spanning from transplantation procedures to Hepatitis C disease were the focus of a recent forum in Sharjah, UAE. ...

Life sentence for man who killed in Aids blunder
Yorkshire Post Today, UK - Apr 5, 2006... with alcohol. That led to mental problems and she also contracted hepatitis C, although, at the time, it was in remission. She moved ...

Shares in Swedish biotech firm Tripep fall
Reuters - Apr 4, 2006... It said it was hard to see a continuation of the study of the drug and would instead concentrate on ChronVac-C against Hepatitis C Virus infections. ...

Hepatitis C Therapy - Eight Healthcare Companies Vie for ABBY Awards, as Ken Kizer, MD, is Honored for Innovative Leadership


Eight Healthcare Companies Vie for ABBY Awards, as Ken Kizer, MD, is Honored for Innovative Leadership
[Press Release] PR Web via Yahoo! News - Apr 03 5:00 AM
Orange, CA (PRWEB) April 3, 2006 -- Eight innovative companies that are significantly improving the way healthcare is delivered will be honored at the Eighth Annual Innovations in HealthcareSM Awards and Event, presented by the Adaptive Business Leaders (ABL) Organization, on June 7, 2006 in Long Beach, California. Four of these honorees will also be chosen to receive ABBY Awards.Save to My Web

Benitec CEO Sara Cunningham to Speak at BIO 2006 on RNA Interference Panel
RedNova - Apr 04 10:14 AM
MOUNTAIN VIEW, Calif., April 4 /PRNewswire/ -- Benitec Ltd.Save to My Web

What's happening
Tahoe Daily Tribune - Apr 04 6:15 AM
Douglas County Parks and Recreation Department is sponsoring along with Tahoe Douglas Firefighters Association and Port of Subs the annual Tot Easter Egg Hunt. Save to My Web

The downward spiral
The Norman Transcript - Apr 01 11:00 PM
Editor's note: This is the first of a three-part story exploring the process, ramifications and recovery o...Save to My Web

Novartis to pay up to $525M to license hepatitis drug
Boston Business Journal - Mar 29 7:32 AM
Novartis Pharma AG has exercised an option to license a hepatitis C drug candidate from Idenix Pharmaceuticals Inc., a deal that could balloon to as much $525 million if the compound is approved for sale in the United States and overseas.Save to My Web

Peginterferon - Screening Test Available to Detect an Antibody to Hepatitis C


Screening Test Available to Detect an Antibody to Hepatitis C
International News Service, Australia - Mar 21, 2006... As recent as 15 years ago, hepatitis C infection developed in about 10 percent of patients who had blood transfusions (especially those who had received ...

Talc Retinopathy
New England Journal of Medicine (subscription), MA - Mar 22, 2006... A recent liver biopsy for the evaluation of the patient's hepatitis C infection showed abundant talc particles under polarized light (Panel C). The hepatic ...

Idenix Announces Licensing of Valopicitabine (NM283) by Novartis
Boursorama, France - Mar 28, 2006... As the prevalence of severe liver disease attributable to hepatitis C rises, deaths due to complications from hepatitis C infection, currently 8,000 to 10,000 ...

GASTROINTESTINAL CARE - DOCTORS DRAW UP STRATEGY TO SAVE
ITNews, Italy - Mar 14, 2006... Alcoholic liver disease and obesity-related fatty liver disease are increasing at an "alarming rate" along with hepatitis C infection. ...

Human Genome Sciences Reports Positive Interim Results of Phase 2 ...
PR Newswire (press release), NY - Mar 14, 2006... Human Genome Sciences is developing Albuferon for use in the treatment of chronic hepatitis C. Hepatitis C infection is an inflammation of the liver caused by ...

Peregrine Pharmaceuticals Adopts Stockholder Rights Agreement
Yahoo! News (press release) - Mar 17, 2006... "Our recently announced positive human safety data for Tarvacin in the treatment of hepatitis C infection and increasing evidence of the broad potential of ...

Tuesday, April 04, 2006


Hepatitis C Therapy - Valeant hepatitis C drug misses goal, shares dive


Valeant hepatitis C drug misses goal, shares dive
Reuters - Mar 21, 2006... Valeant Pharmaceuticals International (VRX.N: Quote, Profile, Research) said on Tuesday a late-stage trial of its chronic hepatitis C treatment Viramidine was ...

Barron's(3/27) Research Reports: How Analysts -2-
Therapeutics Daily (subscription) (press release), PA - Mar 25, 2006Viramidine [a drug for treating chronic hepatitis C in treatment-naive patients] did not meet the non-inferiority efficacy endpoint on an overall intent-to ...

Researchers show laboratory hepatitis C strain is also infectious ...
The Rockefeller University Newswire, NY - Mar 27, 2006... involved a strain of mice called uPA-SCID, which lack an immune system and mimic the liver failure that can accompany chronic hepatitis C infection in people. ...

Clinical Study Results of Actilon for Hepatitis C
EndoNurse, AZ - Mar 21, 2006... clinical study of Actilon (CPG 10101) in combinations with pegylated interferon and/or ribavirin for the treatment of chronic hepatitis C virus (HCV) in the ...

Novelos Therapeutics Closes $15 Million Private Placement
International News Service, Australia - Mar 7, 2006... NOV-002 in lung cancer, in addition to our other clinical development programs, including chemotherapy-resistant ovarian cancer and chronic hepatitis C with NOV ...

AVI BioPharma Successful Ebola Study Results Highlighted in Nature ...
Genetic Engineering News, NY - Mar 7, 2006... infections.". AVI is currently enrolling patients with chronic hepatitis C infection in a Phase I/II clinical trial in the United States. ...